• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

Recent Advances in the Study of [2-(4-bromo-1H-pyrazol-1-yl)ethyl]dimethylamine (CAS: 847818-54-6)

The compound [2-(4-bromo-1H-pyrazol-1-yl)ethyl]dimethylamine (CAS: 847818-54-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its pyrazole core and dimethylamine side chain, has shown promising potential in various therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and mechanisms of action, positioning it as a candidate for further drug development.

One of the key areas of investigation has been the compound's role as a modulator of specific biological pathways. Researchers have identified its interaction with certain enzyme systems, particularly those involved in inflammatory and oncogenic processes. The bromo-substituted pyrazole moiety is believed to contribute to its binding affinity, while the dimethylamine group enhances its solubility and bioavailability. These structural features make it a versatile scaffold for medicinal chemistry applications.

In a recent study published in the Journal of Medicinal Chemistry, the compound was evaluated for its inhibitory effects on a range of kinase targets. The results demonstrated significant activity against several kinases implicated in cancer progression, with IC50 values in the low micromolar range. This suggests potential applications in oncology, particularly for targeted therapies. Additionally, the compound exhibited favorable pharmacokinetic properties in preclinical models, including good oral bioavailability and metabolic stability.

Another line of research has explored the compound's utility in neuropharmacology. Preliminary findings indicate that it may interact with neurotransmitter receptors, particularly those involved in the regulation of dopamine and serotonin. This has sparked interest in its potential use for treating neurological and psychiatric disorders, although further studies are needed to elucidate its exact mechanisms and therapeutic window.

The synthesis of [2-(4-bromo-1H-pyrazol-1-yl)ethyl]dimethylamine has also been optimized in recent years. Novel synthetic routes have been developed to improve yield and purity, making it more accessible for large-scale production. These advancements are critical for supporting ongoing and future clinical trials, ensuring a reliable supply of the compound for research and potential therapeutic use.

In conclusion, [2-(4-bromo-1H-pyrazol-1-yl)ethyl]dimethylamine (CAS: 847818-54-6) represents a promising candidate in the field of drug discovery. Its diverse pharmacological profile, combined with recent advancements in synthesis and characterization, underscores its potential for addressing unmet medical needs. Continued research is essential to fully realize its therapeutic applications and to explore its safety and efficacy in human trials.

• 88106-61-0(1H-Pyrazole-1-ethanamine, N-[2-(1H-pyrazol-1-yl)ethyl]-)
• 381721-56-8(1-2-(1H-pyrazol-1-yl)ethylpiperazine)
• 116476-96-1(1H-Pyrazole, 1,1'-(1,2-ethanediyl)bis[4-bromo-)
• 71229-85-1(4-Bromo-1-ethyl-1H-pyrazole)
• 340967-02-4(N-Ethyl-2-(1H-pyrazol-1-YL)ethanamine)
• 782501-70-6(1-[2-[(2-Aminoethyl)amino]ethyl]-1H-pyrazole)
• 71033-38-0(1-(N,N-DiethylaMinoethyl)pyrazole)
• 13369-72-7(4-bromo-1-(prop-2-en-1-yl)-1H-pyrazole)
• 1071658-18-8(N,N-Dimethyl-2-(1H-pyrazol-1-yl)ethanamine)
• 847818-53-5([3-(4-bromo-1H-pyrazol-1-yl)propyl]dimethylamine)